Novoseven (Eptacog Alfa (Activated))

Eptacog alfa, the active ingredient in Novoseven, is a recombinant activated factor VII presented as an injectable for intravenous use. It is used to control bleeding in patients with hemophilia A or B with inhibitors, and in acquired haemophilia. GNH USA supplies Novoseven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Novoseven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Novoseven is a hemostatic agent that works within the blood‑clotting cascade to manage bleeding disorders.

- Hemophilia A with inhibitors: helps control severe bleeding episodes. - Hemophilia B with inhibitors: helps the manage bleeding during surgical procedures. - Acquired hemophilia: provides temporary hemostasis for spont spont sp  ...  .... . -  .... . - … . - .... 

NovNov...

...